Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose naltrexone and platelet-rich plasma can regrow hair in lichen planopilaris.

Early detection of Graham-Little-Piccardi-Lasseur syndrome is key for better management.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

LPR1 regulates root growth under low phosphate stress independently of SIZ1 in Arabidopsis thaliana.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Low-Level Laser Therapy may help reduce chronic pelvic pain in women.

Lichen planopilaris can cause hair loss on limbs, not just the scalp.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

Targeting LPA could help treat skin disorders.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

Confocal Laser Scanning Microscopy (CLSM) is a useful tool for studying how drugs interact with skin and diagnosing skin disorders, despite some limitations.

Linear lichen planopilaris can affect the trunk, not just the face.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Lichen planopilaris can be accurately diagnosed and effectively treated.

Early and accurate treatment of Lichen Planopilaris is crucial to prevent permanent hair loss in men.

CDP is crucial for lung and hair follicle cell development.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Both environmental and genetic factors contribute to Lichen Planopilaris.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Lichen planus pigmentosus may indicate undetected hepatitis C infection.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

CCL5 is important for the hair growth potential of human dermal papilla cells.

A new genetic mutation in the CAST gene may link PLACK syndrome to alopecia areata.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.

Lichen planopilaris should be considered when diagnosing hair loss in people with darker skin as it may be often missed.

Strict regulations may slow down new LLLT treatments.